Emerging & Overhyped

This is the category where "longevity medicine" marketing runs furthest ahead of the evidence. None of the four items below are without scientific merit — but none are validated for the individual decision-making they're commonly sold for either. We think this section is the most important one on the site, precisely because it's the one most testing companies won't write honestly.

• Weak (for general screening) APOE Genotype TestingGenotyping the APOE gene, which has three common alleles (ε2, ε3, ε4). S$200–400
• Weak Gut Microbiome TestingStool-based sequencing — 16S rRNA or shotgun metagenomics &mdash… S$300–600 (commercial direct-to-consumer)
• Emerging Epigenetic Clocks ("Biological Age" Tests)DNA methylation patterns at specific genomic sites, combined by algorithm into an estimate of “biological age.” The best-known versions &mdash… S$400–700 (commercial "biological age" tests)
• Weak (as a bundle) Bundled "Longevity Panels" / Executive Health PackagesPre-packaged bundles combining dozens of the tests above, typically mixing genuinely Strong ones — CBC, lipids, HbA1c &mdash… S$3,000–15,000+ depending on packagePrice guide →
• Moderate VO2 Max (Cardiopulmonary Exercise Testing)A mask, a bike or treadmill, and a graded test to exhaustion measuring how much oxygen you can actually use. S$250–600
• Moderate Grip StrengthA hand dynamometer, ten seconds, and a number that predicts death better than systolic blood pressure does. S$0–40 (usually included; a home dynamometer costs less than most single blood tests)
• Emerging Continuous Glucose Monitoring in People Without DiabetesA sensor worn on the arm for two weeks, streaming glucose readings to a phone. S$150–400 per 14-day sensor, more with a coaching programme